文献速递胸部肿瘤

电磁导航支气管镜用于外周肺部病灶:前瞻性多中心NAVIGATE研究的一年结果

Electromagnetic Navigation Bronchoscopy for Peripheral Pulmonary Lesions: One-Year Results of the Prospective, Multicenter NAVIGATE Study.
PubMed 文献 · J Thorac Oncol · 2018-11-23

NAVIGATE是一项前瞻性多中心队列研究,在美国29个学术和社区中心连续纳入1215例受试者,评估电磁导航支气管镜(ENB)对外周肺部病灶的诊断效果。12个月诊断率为73%,恶性病变灵敏度69%、特异度100%,ENB相关2级及以上气胸发生率为2.9%。

要点

  • 12个月诊断率为73%,恶性病变灵敏度69%、特异度100%、阳性预测值100%、阴性预测值56%。
  • ENB相关2级及以上气胸发生率为2.9%,2级及以上支气管肺出血为1.5%,4级及以上呼吸衰竭为0.7%。
  • 在可评估的广泛人群中,约四分之三的患者可通过ENB辅助获得诊断,且操作并发症率低。

核心结论

  • NAVIGATE研究显示,在基于前瞻性12个月随访的广泛可评估人群中,约四分之三的患者可通过ENB辅助获得诊断,且操作并发症率低。

研究设计与样本

  • NAVIGATE是一项前瞻性、多中心队列研究,使用superDimension导航系统(Medtronic,明尼阿波利斯,明尼苏达州)评估ENB。
  • 美国队列分析于2015年4月至2016年8月在29个学术和社区中心连续纳入1215例受试者。

主要发现

  • 病灶中位大小为20.0 mm;91%的病例使用透视(其中60%病灶可见),57%使用径向支气管内超声。
  • ENB计划时间中位数为5分钟,ENB特异性操作时间为25分钟。
  • 在1157例接受ENB引导活检的受试者中,94%(1092/1157)完成导航并获取组织。
  • 随访完成率:1个月时为99%,12个月时为80%;12个月诊断率为73%。
  • ENB辅助组织样本病理结果显示44%(484/1092)为恶性;恶性病变的灵敏度、特异度、阳性预测值和阴性预测值分别为69%、100%、100%和56%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Electromagnetic navigation bronchoscopy (ENB) is a minimally invasive technology that guides endoscopic tools to pulmonary lesions. ENB has been evaluated primarily in small, single-center studies; thus, the diagnostic yield in a generalizable setting is unknown. METHODS: NAVIGATE is a prospective, multicenter, cohort study that evaluated ENB using the superDimension navigation system (Medtronic, Minneapolis, Minnesota). In this United States cohort analysis, 1215 consecutive subjects were enrolled at 29 academic and community sites from April 2015 to August 2016. RESULTS: The median lesion size was 20.0 mm. Fluoroscopy was used in 91% of cases (lesions visible in 60%) and radial endobronchial ultrasound in 57%. The median ENB planning time was 5 minutes; the ENB-specific procedure time was 25 minutes. Among 1157 subjects undergoing ENB-guided biopsy, 94% (1092 of 1157) had navigation completed and tissue obtained. Follow-up was completed in 99% of subjects at 1 month and 80% at 12 months. The 12-month diagnostic yield was 73%. Pathology results of the ENB-aided tissue samples showed malignancy in 44% (484 of 1092). Sensitivity, specificity, positive predictive value, and negative predictive value for malignancy were 69%, 100%, 100%, and 56%, respectively. ENB-related Common Terminology Criteria for Adverse Events grade 2 or higher pneumothoraces (requiring admission or chest tube placement) occurred in 2.9%. The ENB-related Common Terminology Criteria for Adverse Events grade 2 or higher bronchopulmonary hemorrhage and grade 4 or higher respiratory failure rates were 1.5% and 0.7%, respectively. CONCLUSIONS: NAVIGATE shows that an ENB-aided diagnosis can be obtained in approximately three-quarters of evaluable patients across a generalizable cohort based on prospective 12-month follow-up in a pragmatic setting with a low procedural complication rate.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Folch EE, Pritchett MA, Nead MA, et al. Electromagnetic Navigation Bronchoscopy for Peripheral Pulmonary Lesions: One-Year Results of the Prospective, Multicenter NAVIGATE Study. J Thorac Oncol. 2018. PMID: 30476574. doi:10.1016/j.jtho.2018.11.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。